Safety profile of lutein-based blue dyes and surgical lights

基于叶黄素的蓝色染料和手术灯的安全性概况

阅读:1

Abstract

INTRODUCTION: The combination of surgical endoillumination and vital dyes has been associated with phototoxicity and retinal damage, despite vital dyes being mainly considered safe. Based on this perspective, the aim of the present study was to evaluate the effect of lutein-based blue dyes (LBBDs) on human retinal pigmented epithelial (ARPE-19) cells and their combination with surgical light exposure. METHODS: ARPE-19 cells were exposed to LBBDs and/or xenon/LED light according to the following experimental design: phase I, exposure to LBBDs only; phase II, exposure to lights only; phase III, single sequential exposure to LBBDs and xenon/LED light; and phase IV, double sequential exposure to LBBDs and xenon/LED light. ATPlite and reactive oxygen species (ROS) detection assays were used to assess the impact on cell viability and ROS production, respectively. RESULTS: No cytotoxic effect was detected following the exposure to LBBDs for 5 min. LED and xenon lights elicited a cytotoxic effect and an overproduction of ROS for an exposure time of ≥5 min. The ROS overproduction following 5-min exposure of ARPE-19 cells to both LED and xenon lights was significantly (p < 0.05) counteracted by pre-treatment with LBBDs. Finally, after double sequential exposure to LBBDs and LED/xenon lights, 2% LBBD induced a significant (p < 0.05) reduction in ROS production compared to both LED/xenon exposure and 1% LBBD/light exposure. DISCUSSION: These findings demonstrated the primary role of light-induced damage as a primary contributing factor to potential retinal damage following peeling procedures. LBBDs provided a protective effect against light-induced oxidative damage, highlighting their potential role in enhancing the safety profile of staining in retinal surgery.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。